634 related articles for article (PubMed ID: 25591863)
21. Pancreatic involvement in cystic fibrosis.
Ozen Alahdab Y; Duman DG
Minerva Med; 2016 Dec; 107(6):427-436. PubMed ID: 27425634
[TBL] [Abstract][Full Text] [Related]
22. Rectal potential difference and the functional expression of CFTR in the gastrointestinal epithelia in cystic fibrosis mouse models.
Weiner SA; Caputo C; Bruscia E; Ferreira EC; Price JE; Krause DS; Egan ME
Pediatr Res; 2008 Jan; 63(1):73-8. PubMed ID: 18043508
[TBL] [Abstract][Full Text] [Related]
23. Progress towards next-generation therapeutics for cystic fibrosis.
O'Neil DA; Fraser-Pitt D
Future Med Chem; 2014 Jun; 6(9):1067-79. PubMed ID: 25068988
[TBL] [Abstract][Full Text] [Related]
24. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
Konrad J; Eber E; Stadlbauer V
Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777
[TBL] [Abstract][Full Text] [Related]
25. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
26. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models.
Wang Y; Wrennall JA; Cai Z; Li H; Sheppard DN
Int J Biochem Cell Biol; 2014 Jul; 52():47-57. PubMed ID: 24727426
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
Fiorotto R; Strazzabosco M
Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
[TBL] [Abstract][Full Text] [Related]
28. Generation of a conditional null allele for Cftr in mice.
Hodges CA; Cotton CU; Palmert MR; Drumm ML
Genesis; 2008 Oct; 46(10):546-52. PubMed ID: 18802965
[TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation.
Bodewes FA; Verkade HJ; Taminiau JA; Borowitz D; Wilschanski M;
J Cyst Fibros; 2015 Mar; 14(2):169-77. PubMed ID: 25677689
[TBL] [Abstract][Full Text] [Related]
30. [Question 5. What management of hepatobiliary injury in the course of cystic fibrosis? Physiopathology and diagnostic criteria of hepatobiliary injury in the course of cystic fibrosis].
Belli DC
Arch Pediatr; 2003 Aug; 10 Suppl 3():487s-489s. PubMed ID: 14671964
[No Abstract] [Full Text] [Related]
31. Animal and model systems for studying cystic fibrosis.
Rosen BH; Chanson M; Gawenis LR; Liu J; Sofoluwe A; Zoso A; Engelhardt JF
J Cyst Fibros; 2018 Mar; 17(2S):S28-S34. PubMed ID: 28939349
[TBL] [Abstract][Full Text] [Related]
32. Comparative biology of cystic fibrosis animal models.
Fisher JT; Zhang Y; Engelhardt JF
Methods Mol Biol; 2011; 742():311-34. PubMed ID: 21547741
[TBL] [Abstract][Full Text] [Related]
33. A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice.
Dimagno MJ; Lee SH; Hao Y; Zhou SY; McKenna BJ; Owyang C
Gastroenterology; 2005 Aug; 129(2):665-81. PubMed ID: 16083720
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of gene-targeted mouse models for cystic fibrosis.
Grubb BR; Boucher RC
Physiol Rev; 1999 Jan; 79(1 Suppl):S193-214. PubMed ID: 9922382
[TBL] [Abstract][Full Text] [Related]
35. Cystic Fibrosis and the Nervous System.
Reznikov LR
Chest; 2017 May; 151(5):1147-1155. PubMed ID: 27876591
[TBL] [Abstract][Full Text] [Related]
36. Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins.
Li L; Falany CN
J Cyst Fibros; 2007 Jan; 6(1):23-30. PubMed ID: 16798114
[TBL] [Abstract][Full Text] [Related]
37. Patterns of GI disease in adulthood associated with mutations in the CFTR gene.
Wilschanski M; Durie PR
Gut; 2007 Aug; 56(8):1153-63. PubMed ID: 17446304
[No Abstract] [Full Text] [Related]
38. Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis.
Gabel ME; Galante GJ; Freedman SD
Semin Respir Crit Care Med; 2019 Dec; 40(6):825-841. PubMed ID: 31659728
[TBL] [Abstract][Full Text] [Related]
39. Mouse models of cystic fibrosis: phenotypic analysis and research applications.
Wilke M; Buijs-Offerman RM; Aarbiou J; Colledge WH; Sheppard DN; Touqui L; Bot A; Jorna H; de Jonge HR; Scholte BJ
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S152-71. PubMed ID: 21658634
[TBL] [Abstract][Full Text] [Related]
40. Development of a porcine model of cystic fibrosis.
Welsh MJ; Rogers CS; Stoltz DA; Meyerholz DK; Prather RS
Trans Am Clin Climatol Assoc; 2009; 120():149-62. PubMed ID: 19768173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
